Patent · US Active

PH20 polypeptide variants, formulations and uses thereof

US11066656B2 · kind B2 · utility

20Cited by
86References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2020
Grant dateJul 20, 2021
Priority date—
Expiry dateJun 25, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.